RxDoctor Payments Data

Melinda Struthoff

Psychiatric/Mental Health · Mason City, IANPI 1265924138

Payments from drug & device makers

$2,847in general payments, 2019–2025

Across 202 payments — averaging $14.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$877
  • Teva Pharmaceuticals USA, Inc.$403
  • Lundbeck LLC$362
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$293
  • Johnson & Johnson$267
  • Neurocrine Biosciences, Inc.$206
  • plus $439 from 6 others

What the payments were for

  • Food & beverage$2,63893%
  • Education$2097%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,847 in reported general payments places this provider in the 75th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$36,523
Medicare patients
139
Services billed
473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl117$159,025
SpravatoEsketamine Hcl54$84,151
NuplazidPimavanserin Tartrate13$62,537
RexultiBrexpiprazole40$55,164
Invega SustennaPaliperidone Palmitate20$49,471
CaplytaLumateperone Tosylate21$35,401
UzedyRisperidone11$33,081
TrintellixVortioxetine Hydrobromide43$20,748
Aripiprazole149$16,024
AuvelityDextromethorphan Hbr/Bupropion18$15,818
Chlorpromazine Hcl36$12,365
Vilazodone Hcl97$9,706
Lurasidone Hcl75$8,386
Duloxetine Hcl229$6,535
Clozapine78$5,791

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$877$159,025117 claims
Johnson & JohnsonSpravato, Invega Sustenna$267$133,62274 claims
Otsuka America Pharmaceutical, Inc.Rexulti$130$55,16440 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$293$35,40121 claims
Teva Pharmaceuticals USA, Inc.Uzedy$403$33,08111 claims
Axsome Therapeutics, Inc.Auvelity$62$15,81818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Mason City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →